Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency

References

• VillanuevaAHernandez-GeaVLlovetJMMedical therapies for hepatocellular carcinoma: a critical view of the evidenceNat Rev Gastroenterol Hepatol2013101344223147664
   PubMed Web of Science ®Google Scholar
• ZhangXNgHLHLuADrug delivery system targeting advanced hepatocellular carcinoma: current and futureNanomedicine201612485386926772424
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• DongYFengSSPolyFSSPoly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials200526306068607615894372
   PubMed Web of Science ®Google Scholar
• SunJBDuanJHDaiSLIn vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriersCancer Lett2007258110911717920762
   PubMed Web of Science ®Google Scholar
• LeeJSHongEKIn vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bionanoparticles as drug carriersCancer Lett201029714415420554107
   PubMed Web of Science ®Google Scholar
• OctaviaYTocchettiCGGabrielsonKLJanssensSCrijnsHJMoensALDoxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesJ Mol Cell Cardiol20125261213122522465037
   PubMed Web of Science ®Google Scholar
• AgudeloDBérubéGTajmir-RiahiHAAn overview on the delivery of antitumor drug doxorubicin by carrier proteinsInt J Biol Macromol20168835436027037051
   PubMed Web of Science ®Google Scholar
• HayekERSpeakmanERehmusEAcute doxorubicin cardiotoxicityN Engl J Med2005352232456245715944435
   PubMedGoogle Scholar
• ChenYJungsuwadeePVoreMButterfieldDASt ClairDKCollateral damage in cancer chemotherapy: oxidative stress in nontargeted tissuesMol Interv20077314715617609521
   PubMedGoogle Scholar
• GuoHZhangDLiTIn vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicinJ Pharm Sci2014103398799324549734
   PubMedGoogle Scholar
• WangSQZhuXFWangXNShenTXiangFLouHXFlavonoids from Malus hupehensis and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cellsPhytochemistry20138711912523276676
   PubMed Web of Science ®Google Scholar
• WangJChungMHXueBMaHMaCHattoriMEstrogenic and antiestrogenic activities of phloridzinBiol Pharm Bull201033459259720410591
   PubMedGoogle Scholar
• WangSQHanXZLiXRenDMWangXNLouHXFlavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cellsBioorg Med Chem Lett201020226411641520932762
   PubMed Web of Science ®Google Scholar
• ZhangTHWangSYShenXEffect of silybin on coxsackie B5 virus infected new born rat heart cells in cultureAcad J Second Military Med Univ1990112143
   Google Scholar
• ChenHZhangTHWeiTProtective effects of silybin on cultured cardiomyocytes with deprivation of oxygen and glucoseAcad J Second Military Med Univ1990112147
   Google Scholar
• LiangRLZyGQbGThe effect of silibinin on Ca2+ channel activity of membrane of isolated myocardium cell from adult ratChin Pharm J19963110594
   Google Scholar
• SalamoneFGalvanoFMarino GammazzaAMarinoASilibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitisDig Liver Dis201244433434222197629
   PubMedGoogle Scholar
• KolhatkarVPolliJEStructural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groupsEur J Pharm Sci2012461–2869922387310
   PubMedGoogle Scholar
• XiaoLPanGAn important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: the apical sodium-dependent bile acid transporter (SLC10A2/ASBT)Clin Res Hepatol Gastroenterol201741550951528336180
   PubMed Web of Science ®Google Scholar
• SchneiderKMAlbersSTrautweinCRole of bile acids in the gut-liver axisJ Hepatol20186851083108529519549
   PubMedGoogle Scholar
• ParkJChoiJUKimKByunYBile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplexBiomaterials201714714515428946130
   PubMed Web of Science ®Google Scholar
• NurunnabiMKhatunZRevuriVDesign and strategies for bile acid mediated therapy and imagingRSC Adv20166787398674002
   Web of Science ®Google Scholar
• LiYZhuCEnhanced hepatic-targeted delivery via oral administration using nanoliposomes functionalized with a novel DSPE–PEG–cholic acid conjugateRSC Adv20166332811028120
   Google Scholar
• LiYYangDZhangYZhuCNovel DSPE-PEG-cholic acid-modified liposomes with hepatic targeting properties improve the anti-tumor efficacy of oral doxorubicin hydrochloride for liver tumor-bearing miceJ Biomed Nanotechnol2017136727736
   Google Scholar
• PercheFPatelNRTorchilinVPAccumulation and toxicity of antibody-targeted doxorubicin-loaded PEG–PE micelles in ovarian cancer cell spheroid modelJ Control Release201216419510222974689
   PubMed Web of Science ®Google Scholar
• MaZJLuLYangJJLariciresinol induces apoptosis in HepG2 cells via mitochondrial-mediated apoptosis pathwayEur J Pharmacol201882111029247613
   PubMed Web of Science ®Google Scholar
• ZhangYZhaoHDiYAntitumor activity of Pinoresinol in vitro: inducing apoptosis and inhibiting HepG2 invasionJ Funct Foods201845206214
   Web of Science ®Google Scholar
• ChoiJSCaoJNaeemMSize-controlled biodegradable nanoparticles: preparation and size-dependent cellular uptake and tumor cell growth inhibitionColloids Surf B Biointerfaces201412254555125108477
   PubMed Web of Science ®Google Scholar
• XingJLiuDZhouGLiposomally formulated phospholipid-conjugated novel near-infrared fluorescence probe for particle size effect on cellular uptake and biodistribution in vivoColloid Surf B2018161588596
   PubMedGoogle Scholar
• AwaadANakamuraMIshimuraKImaging of size-dependent uptake and identification of novel pathways in mouse Peyer’s patches using fluorescent organosilica particlesNanomedicine20128562763621889475
   PubMed Web of Science ®Google Scholar
• CuttsSMRephaeliANudelmanAHmelnitskyIPhillipsDRMolecular basis for the synergistic interaction of Adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9)Cancer Res2001618194820211719450
   PubMedGoogle Scholar
• YokochiTRobertsonKDDoxorubicin inhibits DNMT1, resulting in conditional apoptosisMol Pharmacol20046661415142015340041
   PubMed Web of Science ®Google Scholar
• SaitoGSwansonJALeeKDDrug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activitiesAdv Drug Deliv Rev200355219921512564977
   PubMed Web of Science ®Google Scholar
• ArsuraMCavinLGNuclear factor-kappaB and liver carcinogenesisCancer Lett2005229215716916125305
   PubMed Web of Science ®Google Scholar
• TangJLiLHuangWmiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transitionCancer Lett20153641334325931210
   PubMedGoogle Scholar
• LinXWeiJChenYIsoorientin from Gypsophila elegans induces apoptosis in liver cancer cells via mitochondrial-mediated pathwayJ Ethnopharmacol201618718719427130644
   PubMed Web of Science ®Google Scholar
• KumarNTLiestølKLøbergEMReimsHMMæhlenJPostmortem heart weight: relation to body size and effects of cardiovascular disease and cancerCardiovasc Pathol201423151124121021
   PubMedGoogle Scholar